Chronic graft-versus-host disease: clinical features and grading systems
- PMID: 15168587
- DOI: 10.1532/ijh97.03174
Chronic graft-versus-host disease: clinical features and grading systems
Abstract
Chronic graft-versus-host disease (GVHD) is the prime cause of transplantation-related mortality late after marrow grafting and contributes directly or indirectly to most nonmalignant complications. The main clinical symptoms and diagnostic problems of chronic GVHD are summarized here. A major issue in treating chronic GVHD is to assess disease severity. A critical review of published grading systems failed to demonstrate that any system is better than the others. Prospective validation of the Johns Hopkins grading scale is timely and warranted.
Similar articles
-
Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.Biol Blood Marrow Transplant. 2017 Sep;23(9):1573-1579. doi: 10.1016/j.bbmt.2017.05.017. Epub 2017 May 19. Biol Blood Marrow Transplant. 2017. PMID: 28533059 Free PMC article.
-
Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.Biol Blood Marrow Transplant. 2014 Apr;20(4):556-63. doi: 10.1016/j.bbmt.2014.01.010. Epub 2014 Jan 18. Biol Blood Marrow Transplant. 2014. PMID: 24447907
-
Diagnosis and manifestations of chronic graft-versus-host disease.Best Pract Res Clin Haematol. 2008 Jun;21(2):251-7. doi: 10.1016/j.beha.2008.02.008. Best Pract Res Clin Haematol. 2008. PMID: 18503990 Review.
-
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56. doi: 10.1016/j.bbmt.2005.09.004. Biol Blood Marrow Transplant. 2005. PMID: 16338616
-
Grading Histopathology Features of Graft-versus-host Disease in Animal Models; A Systematic Review.Iran J Allergy Asthma Immunol. 2024 Apr 27;23(3):235-244. doi: 10.18502/ijaai.v23i3.15634. Iran J Allergy Asthma Immunol. 2024. PMID: 39422384
Cited by
-
Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype.Int J Hematol. 2010 Apr;91(3):436-45. doi: 10.1007/s12185-010-0515-y. Epub 2010 Feb 25. Int J Hematol. 2010. PMID: 20180052
-
Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).Biol Blood Marrow Transplant. 2008 Sep;14(9):1017-1021. doi: 10.1016/j.bbmt.2008.06.013. Biol Blood Marrow Transplant. 2008. PMID: 18721764 Free PMC article. Clinical Trial.
-
Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease.Int J Hematol. 2006 Jan;83(1):80-5. doi: 10.1532/IJH97.05111. Int J Hematol. 2006. PMID: 16443558 Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources